212 related articles for article (PubMed ID: 24123380)
41. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
[TBL] [Abstract][Full Text] [Related]
42. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics.
Heinrichs S; Kulkarni RV; Bueso-Ramos CE; Levine RL; Loh ML; Li C; Neuberg D; Kornblau SM; Issa JP; Gilliland DG; Garcia-Manero G; Kantarjian HM; Estey EH; Look AT
Leukemia; 2009 Sep; 23(9):1605-13. PubMed ID: 19387468
[TBL] [Abstract][Full Text] [Related]
43. The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome.
Ou Y; Yang Y; Yu H; Zhang X; Liu M; Wu Y
Int J Lab Hematol; 2021 Oct; 43(5):1062-1069. PubMed ID: 33650312
[TBL] [Abstract][Full Text] [Related]
44. Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS.
Gondek LP; Tiu R; Haddad AS; O'Keefe CL; Sekeres MA; Theil KS; Maciejewski JP
Leukemia; 2007 Sep; 21(9):2058-61. PubMed ID: 17525728
[No Abstract] [Full Text] [Related]
45. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.
Afable MG; Wlodarski M; Makishima H; Shaik M; Sekeres MA; Tiu RV; Kalaycio M; O'Keefe CL; Maciejewski JP
Blood; 2011 Jun; 117(25):6876-84. PubMed ID: 21527527
[TBL] [Abstract][Full Text] [Related]
46. FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes?
Yang W; Stotler B; Sevilla DW; Emmons FN; Murty VV; Alobeid B; Bhagat G
Leuk Res; 2010 Apr; 34(4):420-5. PubMed ID: 19800120
[TBL] [Abstract][Full Text] [Related]
47. Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis.
Kunze K; Gamerdinger U; Leßig-Owlanj J; Sorokina M; Brobeil A; Tur MK; Blau W; Burchardt A; Käbisch A; Schliesser G; Kiehl M; Rosenwald A; Rummel M; Grimminger F; Hain T; Chakraborty T; Bräuninger A; Gattenlöhner S
Pathol Res Pract; 2014 Jun; 210(6):369-76. PubMed ID: 24674452
[TBL] [Abstract][Full Text] [Related]
48. Prognostic molecular markers in myelodysplastic syndromes.
Neukirchen J; Haas R; Germing U
Expert Rev Hematol; 2009 Oct; 2(5):563-75. PubMed ID: 21083021
[TBL] [Abstract][Full Text] [Related]
49. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.
Steensma DP; List AF
Mayo Clin Proc; 2005 May; 80(5):681-98. PubMed ID: 15887439
[TBL] [Abstract][Full Text] [Related]
50. Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
Schwabkey ZI; Al Ali N; Chan O; Sallman DA; Padron E; Kuykendall AT; Talati C; Sweet K; Lancet JE; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e52-e56. PubMed ID: 33093008
[TBL] [Abstract][Full Text] [Related]
51. Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Cancer Genet Cytogenet; 2010 Jan; 196(2):159-66. PubMed ID: 20082852
[TBL] [Abstract][Full Text] [Related]
52. Revised international prognostic scoring system for myelodysplastic syndromes.
Greenberg PL; Tuechler H; Schanz J; Sanz G; Garcia-Manero G; Solé F; Bennett JM; Bowen D; Fenaux P; Dreyfus F; Kantarjian H; Kuendgen A; Levis A; Malcovati L; Cazzola M; Cermak J; Fonatsch C; Le Beau MM; Slovak ML; Krieger O; Luebbert M; Maciejewski J; Magalhaes SM; Miyazaki Y; Pfeilstöcker M; Sekeres M; Sperr WR; Stauder R; Tauro S; Valent P; Vallespi T; van de Loosdrecht AA; Germing U; Haase D
Blood; 2012 Sep; 120(12):2454-65. PubMed ID: 22740453
[TBL] [Abstract][Full Text] [Related]
53. Prognostic scoring systems in MDS.
Germing U; Kündgen A
Leuk Res; 2012 Dec; 36(12):1463-9. PubMed ID: 22980036
[TBL] [Abstract][Full Text] [Related]
54. The changing classification of myelodysplastic syndromes: what's in a name?
Steensma DP
Hematology Am Soc Hematol Educ Program; 2009; ():645-55. PubMed ID: 20008250
[TBL] [Abstract][Full Text] [Related]
55. Updates in cytogenetics and molecular markers in MDS.
Tiu RV; Visconte V; Traina F; Schwandt A; Maciejewski JP
Curr Hematol Malig Rep; 2011 Jun; 6(2):126-35. PubMed ID: 21340513
[TBL] [Abstract][Full Text] [Related]
56. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).
Germing U; Hildebrandt B; Pfeilstöcker M; Nösslinger T; Valent P; Fonatsch C; Lübbert M; Haase D; Steidl C; Krieger O; Stauder R; Giagounidis AA; Strupp C; Kündgen A; Mueller T; Haas R; Gattermann N; Aul C
Leukemia; 2005 Dec; 19(12):2223-31. PubMed ID: 16193087
[TBL] [Abstract][Full Text] [Related]
57. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
Aul C; Giagounidis A; Germing U; Ganser A
Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
[TBL] [Abstract][Full Text] [Related]
58. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays.
Ahmad A; Iqbal MA
Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919
[TBL] [Abstract][Full Text] [Related]
59. Evaluating the prognosis of patients with myelodysplastic syndromes.
Aul C; Giagounidis A; Germing U; Ganser A
Ann Hematol; 2002 Sep; 81(9):485-97. PubMed ID: 12373348
[TBL] [Abstract][Full Text] [Related]
60. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
